The recent challenges in global distribution have highlighted the value of securing vital medications like Ivermectin. Trusting on overseas manufacturers exposes countries to significant vulnerabilities, including transportation delays, expense fluctuations, and even geopolitical threats. Moving towards domestic production of Ivermectin offers a mu